98%
921
2 minutes
20
The controlled generation and delivery of hydrogen sulfide (HS), a critical gasotransmitter involved in various physiological and therapeutic processes, remain significant challenges, driving the need for innovative and responsive chemical tools. In this study, we developed thionocarbamate derivatives based on the boron dipyrromethene (BODIPY) scaffold, which rapidly release carbonyl sulfide (COS) upon photoactivation, allowing HS generation under physiological conditions. These systems exhibit an exceptional uncaging rate compared with other reported structures, enabling rapid and precisely controlled HS releases, as verified through live-cell imaging studies. In particular, the photolysis rate of the thionocarbamate derivatives was found to be more than 100-fold faster than the corresponding carbamates, a result that is explained through density functional theory (DFT) calculations as arising from the thermodynamic instability of thiocarbonyls, offering a new strategy in photocage design. These results also highlight the potential of using thionocarbamate-based BODIPY derivatives as versatile tools for HS delivery, paving the way for their application in HS-related therapies and studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d5tb01313e | DOI Listing |
J Mater Chem B
August 2025
Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 07103, USA.
The controlled generation and delivery of hydrogen sulfide (HS), a critical gasotransmitter involved in various physiological and therapeutic processes, remain significant challenges, driving the need for innovative and responsive chemical tools. In this study, we developed thionocarbamate derivatives based on the boron dipyrromethene (BODIPY) scaffold, which rapidly release carbonyl sulfide (COS) upon photoactivation, allowing HS generation under physiological conditions. These systems exhibit an exceptional uncaging rate compared with other reported structures, enabling rapid and precisely controlled HS releases, as verified through live-cell imaging studies.
View Article and Find Full Text PDFJ Org Chem
November 2006
Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602-5700, USA.
Synthetic routes to 4'-(2,2-difluorospirocyclopropane) analogues of adenosine, cytidine, and uridine are described. Treatment of 2',3'-O-isopropylidene-4',5'-unsaturated compounds derived from adenosine and uridine with difluorocarbene (generated from PhHgCF3 and NaI) gave diastereomeric mixtures of the 2,2-difluorospirocyclopropane adducts. Stereoselectivity resulting from hindrance by the isopropylidene group favored addition at the beta face.
View Article and Find Full Text PDFJ Org Chem
July 2004
Facultad de Química, Pontificia Universidad Católica de Chile, Casilla 306, Santiago 22, Chile.
The title reactions are subjected to a kinetic study in water, at 25.0 degrees C, and an ionic strength of 0.2 M (KCl).
View Article and Find Full Text PDFBioorg Med Chem Lett
January 2004
Department of Bioorganic Chemistry, CV Therapeutics, 3172 Porter Drive, Palo Alto, CA 94304, USA.
The SAR for the affinity to the A(1) adenosine receptor and relative intrinsic efficacy (IE, [(35)S]-GTPgammaS binding) of a series of 5'-carbamate and 5'-thionocarbamate derivatives of tecadenoson is described. Based on this SAR, selected compounds were evaluated in guinea pig isolated hearts to determine whether they were partial or full agonists with respect to their negative dromotropism, an A(1) AdoR mediated effect. Progress towards obtaining a partial A(1) AdoR agonist to potentially control ventricular rate during atrial fibrillation has been made with the discovery of several potent partial A(1) AdoR agonists (compounds 13, 14, and 17).
View Article and Find Full Text PDF